Related Experiment Videos

Proteins associated with emergence of the resistance to lethal glucocorticoid actions in P1798 mouse lymphosarcoma

Cancer Research
|September 1, 1981
PubMed

Insights

Researchers identified protein changes in corticosteroid-resistant P1798 mouse lymphosarcoma cells using two-dimensional gel electrophoresis. These protein synthesis differences may explain tumor cell resistance to glucocorticoids.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Corticosteroids are used in cancer therapy, but drug resistance limits their efficacy.
  • Understanding the molecular mechanisms of corticosteroid resistance in tumors is crucial for improving treatment outcomes.

Purpose of the Study:

  • To investigate protein expression differences between corticosteroid-sensitive and resistant P1798 mouse lymphosarcoma cells.
  • To identify specific proteins whose synthesis is altered in resistant tumor cells.

Main Methods:

  • Two-dimensional gel electrophoresis was employed to analyze newly synthesized proteins labeled with [35S]methionine.
  • Comparative proteomic analysis was performed on sensitive and resistant cell lines.

Main Results:

  • Seven protein expression differences were observed between sensitive and resistant cells.
  • A novel protein (approx. 36,000 molecular weight) appeared in resistant cells.
  • Four proteins increased and two decreased in resistant cells compared to sensitive cells.
  • Protein differences were not induced by endogenous glucocorticoids or associated with stromal/blood components.

Conclusions:

  • Alterations in the synthesis rates of specific proteins are associated with glucocorticoid resistance in P1798 mouse lymphosarcoma.
  • These protein changes may represent a key mechanism underlying tumor cell resistance to glucocorticoid-induced cell death.

Related Concept Videos